Frontiers in Immunology · 2020 · 90 citations · 31 references
Life SciencesImmunologyInfectious DiseasesInflammationInnate ImmunityTranscriptomicsAntiviral ImmunityAntiviral TherapyInflammatory SignalingInnate Immune Signaling PathwaysInterferon ResponsesVaccines For Emerging PathogensAntiviral Mechanisms Of ActionInhibition Of Interferon ResponsesInterferon Gene InductionInterferon-induced GenesInterferon-mediated Innate ImmunitySars-cov-2 InfectionType I Interferon PathwaysValproic Acid
Current guidelines for COVID-19 management recommend the utilization of various repurposed drugs. Despite ongoing research toward the development of a vaccine against SARS-CoV-2, such a vaccine will not be available in time to contribute to the containment of the ongoing pandemic. Therefore, there is an urgent need to develop a framework for the rapid identification of novel targets for diagnostic and therapeutic interventions. We analyzed publicly available transcriptomic datasets of SARS-CoV infected humans and mammals to identify consistent differentially expressed genes then validated in SARS-CoV-2 infected epithelial cells transcriptomic datasets. Comprehensive toxicogenomic analysis of the identified genes to identify possible interactions with clinically proven drugs was carried out. We identified IFITM3 as an early upregulated gene, and valproic acid was found to enhance its mRNA expression as well as induce its antiviral action. These findings indicate that analysis of publicly available transcriptomic and toxicogenomic data represents a rapid approach for the identification of novel targets and molecules that can modify the action of such targets during the early phases of emerging infections like COVID-19.
31
NCBI GEO: archive for functional genomics data sets—update
Tanya Barrett, Stephen E. Wilhite, Pierre Ledoux et al. · Nucleic Acids Research · 2012 · 10.8K citations · Full text
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon, Gwendolyn Μ. Jang, Mehdi Bouhaddou et al. · Nature · 2020 · 4.9K citations · Full text
Rudragouda Channappanavar, Anthony R. Fehr, Rahul Vijay et al. · Cell Host & Microbe · 2016 · 1.5K citations · Full text
The Comparative Toxicogenomics Database: update 2019
Allan Peter Davis, Cynthia Grondin, Robin J. Johnson et al. · Nucleic Acids Research · 2018 · 1.1K citations · Full text
Pharmacy, Bioinformatics, Toxicology +17
IFITM3 restricts the morbidity and mortality associated with influenza
Aaron R. Everitt, Simon Clare, Thomas Pertel et al. · Nature · 2012 · 796 citations · Full text